UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~December~~June 28, ~~2024~~2025


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ____ to ____

Commission File Number 0-17795

CIRRUS LOGIC, INC.

(Exact name of registrant as specified in its charter)

Delaware

77-0024818

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

800 W. 6th Street

Austin,

Texas

78701

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code:

(512)

851-4000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common stock, $0.001 par value

CRUS

The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.


Large Accelerated Filer	☑	Accelerated Filer	☐
Non-accelerated Filer	☐	Smaller Reporting Company	☐
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☑

The number of shares of the registrant's common stock, $0.001 par value, outstanding as of August 1, 2025 was 51,332,178.

CIRRUS LOGIC, INC.

FORM 10-Q QUARTERLY REPORT

QUARTERLY PERIOD ENDED ~~DECEMBER~~JUNE 28, ~~2024~~2025

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Condensed Balance Sheets - December 28, 2024 (unaudited) and March 30, 2024	3
	Consolidated Condensed Balance Sheets - June 28, 2025 (unaudited) and March 29, 2025	3
	Consolidated Condensed Statements of Income (unaudited) - Three and Nine Months Ended December 28, 2024 and December 30, 2023	4
	Consolidated Condensed Statements of Income (unaudited) - Three Months Ended June 28, 2025 and June 29, 2024	4
	Consolidated Condensed Statements of Comprehensive Income (unaudited) - Three and Nine Months Ended December 28, 2024 and December 30, 2023	5
	Consolidated Condensed Statements of Comprehensive Income (unaudited) - Three Months Ended June 28, 2025 and June 29, 2024	5
	Consolidated Condensed Statements of Cash Flows (unaudited) - Nine Months Ended December 28, 2024 and December 30, 2023	6
	Consolidated Condensed Statements of Cash Flows (unaudited) - Three Months Ended June 28, 2025 and June 29, 2024	6
	Consolidated Condensed Statements of Stockholders' Equity (unaudited) - Three and Nine Months Ended December 28, 2024 and December 30, 2023	7
	Consolidated Condensed Statements of Stockholders' Equity (unaudited) - Three Months Ended June 28, 2025 and June 29, 2024	7
	Notes to Consolidated Condensed Financial Statements (unaudited)	8
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	21
Item 4.	Controls and Procedures	21
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	2221
Item 1A.	Risk Factors	2221
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2423
Item 3.	Defaults Upon Senior Securities	2423
Item 4.	Mine Safety Disclosures	2423
Item 5.	Other Information	24
Item 6.	Exhibits	2524
	Signatures	25

Part I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CIRRUS LOGIC, INC.

CONSOLIDATED CONDENSED BALANCE SHEETS

(in thousands)

	December 28,		March 30,
	June 28,		March 29,
	2024		2024
	2025		2025
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	~~526~~548,~~444~~870	$	~~502~~539,~~764~~620
Marketable securities	3765,~~535~~925		2356,~~778~~160
Accounts receivable, net	~~261~~214,~~943~~085		~~162~~216,~~478~~009
Inventories	~~275~~278,~~558~~984		~~227~~299,~~248~~092
Prepaid assets	5144,~~323~~243		48,~~047~~236
Prepaid wafers	6661,~~113~~934		8652,~~679~~560
Other current assets	3127,~~534~~081		5528,~~198~~057
Total current assets	1,~~250~~241,~~450~~122		1,~~106~~239,~~192~~734
Long-term marketable securities	~~252~~232,~~594~~959		~~173~~239,~~374~~036
Right-of-use lease assets	~~129~~123,~~597~~718		~~138~~126,~~288~~688
Property and equipment, net	~~163~~154,~~837~~340		~~170~~159,~~175~~900
Intangibles, net	2325,~~957~~718		2927,~~578~~461
Goodwill	435,936		435,936
Deferred tax assets	4054,~~895~~037		48,~~649~~150
Long-term prepaid wafers	~~23,020~~—		6015,~~750~~512
Other assets	4226,~~954~~887		6834,~~634~~656
Total assets	$	2,~~363~~294,~~240~~717	$	2,~~231~~327,~~576~~073
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$	7766,~~907~~321	$	5563,~~545~~162
Accrued salaries and benefits	4843,~~029~~146		4752,~~612~~075
Software license agreements	2621,~~985~~511		3126,~~866~~745
Current lease liabilities	21,~~858~~075		2021,~~640~~811
Other accrued liabilities	36,~~134~~625		3031,~~730~~395
Total current liabilities	~~210~~188,~~913~~678		~~186~~195,~~393~~188
Long-term liabilities:
Non-current lease liabilities	~~124~~120,~~622~~272		~~134~~121,~~576~~908
Non-current income taxes	4344,~~401~~693		5244,~~013~~040
Software license agreements	2110,~~506~~790		4116,~~073~~488
Other long-term liabilities	—		507
Total long-term liabilities	175,755		182,436
Total long-term liabilities	189,529		228,169
Stockholders' equity:
Capital stock	1,~~840~~881,~~791~~472		1,~~760~~860,~~701~~281
Accumulated earnings	~~124~~49,~~101~~035		5890,~~916~~351
Accumulated other comprehensive loss	(~~2,094~~223)		(21,~~603~~183)
Total stockholders' equity	1,~~962~~930,~~798~~284		1,~~817~~949,~~014~~449
Total liabilities and stockholders' equity	$	2,~~363~~294,~~240~~717	$	2,~~231~~327,~~576~~073

The accompanying notes are an integral part of these consolidated condensed financial statements.

CIRRUS LOGIC, INC.

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(in thousands, except per share amounts; unaudited)

	Three Months Ended				~~Nine Months Ended~~
	December 28,		December 30,		December 28,		December 30,
	June 28,		June 29,
	2024		2023		2024		2023
	2025		2024
Net sales	$	~~555~~407,~~738~~272	$	~~618~~374,~~984~~026	$	~~1,471,621~~	$	~~1,417,063~~
Cost of sales	~~257~~193,~~951~~242		~~301~~185,~~520~~101		~~702,319~~		~~693,616~~
Gross profit	~~297~~214,~~787~~030		~~317~~188,~~464~~925		~~769,302~~		~~723,447~~
Operating expenses
Research and development	~~112~~102,~~976~~892		~~112~~105,~~672~~363		~~331,264~~		~~323,092~~
Selling, general and administrative	3938,~~042~~744		3736,~~604~~770		~~113,625~~		~~107,306~~
Restructuring costs	—		(360)		—		1,959
Total operating expenses	141,636		142,133
Total operating expenses	152,018		149,916		444,889		432,357
Income from operations	72,394		46,792
Income from operations	145,769		167,548		324,413		291,090
Interest income	8,840		8,420
Interest income	8,364		5,124		25,162		13,914
Interest expense	(218)		(218)
Interest expense	(218)		(235)		(680)		(696)
Other income (expense)	(388)		1,609
Other income (expense)	(214)		(337)		1,414		(30)
Income before income taxes	80,628		56,603
Income before income taxes	153,701		172,100		350,309		304,278
Provision for income taxes	19,931		14,508
Provision for income taxes	37,696		33,377		90,069		74,548
Net income	$	60,697	$	42,095
Net income	$	116,005	$	138,723	$	260,240	$	229,730
Basic earnings per share	$	1.17	$	0.79
Basic earnings per share	$	2.19	$	2.57	$	4.89	$	4.22
Diluted earnings per share	$	1.14	$	0.76
Diluted earnings per share	$	2.11	$	2.50	$	4.69	$	4.09
Basic weighted average common shares outstanding	51,727		53,433
Basic weighted average common shares outstanding	53,081		54,016		53,263		54,449
Diluted weighted average common shares outstanding	53,319		55,665
Diluted weighted average common shares outstanding	55,076		55,592		55,529		56,160

The accompanying notes are an integral part of these consolidated condensed financial statements.

CIRRUS LOGIC, INC.

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands; unaudited)

Three Months Ended

~~Nine Months Ended~~

December 28,

December 30,

December 28,

December 30,

June 28,

June 29,

2024

2023

2024

2023

2025

2024

Net income

~~116~~60,~~005~~697

~~138~~42,~~723~~095

~~260,240~~

~~229,730~~

Other comprehensive loss, before tax

Foreign currency translation gain (loss)

~~(937)~~769

~~445~~(358)

~~(578)~~

~~(347)~~

Unrealized gain (loss) on marketable securities

~~(3,116)~~242

~~1,266~~(358)

~~1,377~~

~~1,505~~

Benefit (provision) for income taxes

~~654~~(51)

~~(266)~~75

~~(290)~~

~~(316)~~

Comprehensive income

~~112~~61,~~606~~657

~~140~~41,~~168~~454

~~260,749~~

~~230,572~~

The accompanying notes are an integral part of these consolidated condensed financial statements.

CIRRUS LOGIC, INC.

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)

	Nine Months Ended
	Three Months Ended
	December 28,		December 30,
	June 28,		June 29,
	2024		2023
	2025		2024
Cash flows from operating activities:
Net income	$	~~260~~60,~~240~~697	$	~~229~~42,~~730~~095
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3713,~~801~~173		3612,~~283~~359
Stock-based compensation expense	6420,~~655~~809		6721,~~113~~385
Deferred income taxes	7(5,~~466~~938)		1(5,~~122~~897)
Loss on retirement or write-off of long-lived assets	381		74
Other non-cash adjustments	(16)		1,104
Other non-cash adjustments	812		2,276
Restructuring costs	—		1,959
Net change in operating assets and liabilities:
Accounts receivable	~~(99~~1,~~465)~~924		(6727,~~558~~601)
Inventories	~~(48~~20,~~310)~~108		(235,~~223~~318)
Prepaid wafers	586,~~296~~138		3612,~~654~~354
Other assets	(42,~~080)~~014		11(5,~~682~~459)
Accounts payable and other accrued liabilities	17(8,~~749~~806)		~~(32~~12,~~201)~~037
Income taxes payable	186,~~435~~028		830,~~598~~102
Acquisition-related liabilities	—		(21,361)
Net cash provided by operating activities	116,131		87,161
Net cash provided by operating activities	313,980		251,148
Cash flows from investing activities:
Maturities and sales of available-for-sale marketable securities	2522,~~904~~990		2312,~~418~~646
Purchases of available-for-sale marketable securities	(~~117~~26,~~505~~435)		(5369,~~525~~060)
Purchases of property, equipment and software	(192,~~347~~638)		(309,~~593~~990)
Investments in technology	(~~225~~132)		(57155)
Net cash used in investing activities	(~~111~~6,~~173~~215)		(6066,~~757~~559)
Cash flows from financing activities:
Net proceeds from the issuance of common stock	~~15,433~~382		~~610~~10,196
Repurchase of stock to satisfy employee tax withholding obligations	(331,~~538~~049)		(161,~~851~~219)
Repurchase and retirement of common stock	(~~161~~99,~~022~~999)		(~~136~~40,~~003~~992)
Net cash used in financing activities	(~~179~~100,~~127~~666)		(~~152~~32,~~244~~015)
Net increase in cash and cash equivalents	23,680		38,147
Net increase (decrease) in cash and cash equivalents	9,250		(11,413)
Cash and cash equivalents at beginning of period	~~502~~539,~~764~~620		~~445~~502,~~784~~764
Cash and cash equivalents at end of period	$	~~526~~548,~~444~~870	$	~~483~~491,~~931~~351

The accompanying notes are an integral part of these consolidated condensed financial statements.

CIRRUS LOGIC, INC.

CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

(in thousands; unaudited)

	Common Stock			Additional Paid-In Capital		Accumulated Earnings (Deficit)		Accumulated Other Comprehensive Loss		Total
Three Months Ended	Shares	Amount
Balance, September 23, 2023	54,237	$	54	$	1,712,656	$	(1,213)	$	(3,142)	$	1,708,355
Net income	—	—		—		138,723		—		138,723
Change in unrealized gain (loss) on marketable securities, net of tax	—	—		—		—		1,000		1,000
Change in foreign currency translation adjustments	—	—		—		—		445		445
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	473	1		47		(13,719)		—		(13,671)
Repurchase and retirement of common stock	(781)	(1)		—		(57,158)		—		(57,159)
Stock-based compensation	—	—		23,067		—		—		23,067
Balance, December 30, 2023	53,929	$	54	$	1,735,770	$	66,633	$	(1,697)	$	1,800,760
Balance, September 28, 2024	53,132	$	53	$	1,819,536	$	107,233	$	1,305	$	1,928,127
Net income	—	—		—		116,005		—		116,005
Change in unrealized gain (loss) on marketable securities, net of tax	—	—		—		—		(2,462)		(2,462)
Change in foreign currency translation adjustments	—	—		—		—		(937)		(937)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	685	1		379		(29,112)		—		(28,732)
Repurchase and retirement of common stock	(679)	(1)		—		(70,025)		—		(70,026)
Stock-based compensation	—	—		20,823		—		—		20,823
Balance, December 28, 2024	53,138	$	53	$	1,840,738	$	124,101	$	(2,094)	$	1,962,798
Nine Months Ended
Balance, March 25, 2023	55,098	$	55	$	1,670,086	$	(9,320)	$	(2,539)	$	1,658,282
Net income	—	—		—		229,730		—		229,730
Change in unrealized gain (loss) on marketable securities, net of tax	—	—		—		—		1,189		1,189
Change in foreign currency translation adjustments	—	—		—		—		(347)		(347)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	589	1		611		(16,845)		—		(16,233)
Repurchase and retirement of common stock	(1,758)	(2)		—		(136,932)		—		(136,934)
Stock-based compensation	—	—		65,073		—		—		65,073
Balance, December 30, 2023	53,929	$	54	$	1,735,770	$	66,633	$	(1,697)	$	1,800,760
Balance, March 30, 2024	53,491	$	53	$	1,760,648	$	58,916	$	(2,603)	$	1,817,014
Net income	—	—		—		~~260~~42,~~240~~095		—		~~260~~42,~~240~~095
Change in unrealized gain (loss) on marketable securities, net of tax	—	—		—		—		~~1,087~~(283)		~~1,087~~(283)
Change in foreign currency translation adjustments	—	—		—		—		(~~578~~358)		(~~578~~358)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	~~1,044~~205	1—		1510,~~435~~197		(331,~~538~~219)		—		~~(18~~8,~~102)~~978
Repurchase and retirement of common stock	(~~1,397~~361)	~~(1)~~—		—		(~~161~~41,~~517~~201)		—		(~~161~~41,~~518~~201)
Stock-based compensation	—	—		6421,~~655~~385		—		—		6421,~~655~~385
Balance, December 28, 2024	53,138	$	53	$	1,840,738	$	124,101	$	(2,094)	$	1,962,798
Balance, June 29, 2024	53,335	$	53	$	1,792,230	$	58,591	$	(3,244)	$	1,847,630
Balance, March 29, 2025	52,291	$	52	$	1,860,229	$	90,351	$	(1,183)	$	1,949,449
Net income	—	—		—		60,697		—		60,697
Change in unrealized gain (loss) on marketable securities, net of tax	—	—		—		—		191		191
Change in foreign currency translation adjustments	—	—		—		—		769		769
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	37	—		383		(1,049)		—		(666)
Repurchase and retirement of common stock	(1,014)	(1)		—		(100,964)		—		(100,965)
Stock-based compensation	—	—		20,809		—		—		20,809
Balance, June 28, 2025	51,314	$	51	$	1,881,421	$	49,035	$	(223)	$	1,930,284

The accompanying notes are an integral part of these consolidated condensed financial statements.

CIRRUS LOGIC, INC.

NOTES TO THE CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(unaudited)

1. Basis of Presentation

The unaudited consolidated condensed financial statements have been prepared by Cirrus Logic, Inc. (“Cirrus Logic,” “we,” “us,” “our,” or the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). The accompanying unaudited consolidated condensed financial statements do not include complete footnotes and financial presentations. As a result, these financial statements should be read along with the audited consolidated financial statements and notes thereto for the year ended March 3029, ~~2024~~2025, included in our Annual Report on Form 10-K filed with the Commission on May 2423, ~~2024~~2025. In our opinion, the financial statements reflect all material adjustments, including normal recurring adjustments, necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented. The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect reported assets, liabilities, revenues and expenses. Actual results could differ from those estimates and assumptions. Moreover, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the entire year.

2. Recently Issued Accounting Pronouncements

In ~~November~~December 2023, the FASB issued ASU 2023-0709, ~~Segment~~Income ~~Reporting~~Taxes (Topic ~~280~~740): - Improvements to ~~Reportable~~Income ~~Segment~~Tax Disclosures. ~~This~~The ~~ASU~~guidance ~~requires~~provides ~~(1)~~qualitative ~~interim~~ and ~~annual~~quantitative ~~disclosure~~updates ~~of significant segment expenses that are regularly provided~~ to the ~~chief~~rate ~~operating~~reconciliation ~~decision maker ("CODM")~~ and ~~included~~income ~~within~~taxes ~~each~~paid ~~reported measure of a segment’s profit or loss, (2) interim~~ disclosures ~~about a reportable segment’s profit or loss and assets that are currently required annually~~, ~~and~~requiring (3) disclosure of the position and title of the CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. In the event the CODM uses more ~~than~~consistent ~~one~~categories ~~measure of a segment's profit or loss in assessing performance~~ and ~~allocation~~greater ofdisaggregation ~~resources, clarification~~ of ~~disclosure~~information ~~requirements~~by ~~is provided~~jurisdiction. ~~Additionally,~~This aASU ~~company with a single reportable segment~~ is ~~required~~effective tofor ~~provide~~financial ~~all~~statements ~~the~~issued ~~disclosures prescribed under this ASU. The guidance is effective~~ for annual periods beginning after December 15, ~~2023~~2024, ~~and~~with ~~interim~~early ~~periods~~adoption ~~within fiscal years beginning after December 15~~permitted, ~~2024,~~ to be applied ~~retrospectively~~on toa ~~all~~prospective ~~periods presented~~basis, ~~with~~although ~~early~~retrospective ~~adoption~~application is also permitted. The Company is currently evaluating the impact of this ~~new~~ guidance on financial statement disclosures and expects to provide these disclosures in the fourth quarter fiscal year 2026.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. The guidance provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, requiring more consistent categories and greater disaggregation of information by jurisdiction. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted, to be applied on a prospective basis, although retrospective application is also permitted. The Company is currently evaluating the impact of this guidance on financial statement disclosures.

In November 2024, FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220-40): Disaggregation of Income Statement Expenses, which requires disaggregation of certain expense categories in the notes to the financial statements in order to provide enhanced transparency into the expense captions presented on the face of the income statement. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption and prospective or retrospective application permitted. The Company is currently evaluating the impact of this guidance on financial statement disclosures.

3. Marketable Securities

The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP. Marketable securities are categorized on the Consolidated Condensed Balance Sheet as "Marketable securities", within the short-term or long-term classification, as appropriate, based on the original maturity.

The following table is a summary of available-for-sale securities at June 28, 2025 (in thousands):


As of June 28, 2025	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value (Net Carrying Amount)
Corporate debt securities	$	288,334	$	1,846	$	(15)	$	290,165

U.S. Treasury securities	8,686		35		(2)		8,719



Total securities	$	297,020	$	1,881	$	(17)	$	298,884

The Company typically invests in highly-rated securities with original maturities generally ranging from one to three years. The Company's specifically identified gross unrealized losses were immaterial related to securities with total amortized costs of approximately $15.6 million at June 28, 2025. There were no securities in a continuous unrealized loss position for more than 12 months as of June 28, 2025. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management. The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and

As of December 28, 2024	AmortizedCost		GrossUnrealizedGains		GrossUnrealizedLosses		EstimatedFair Value(Net CarryingAmount)
Corporate debt securities	$	279,226	$	820	$	(359)	$	279,687
U.S. Treasury securities	10,234		34		(10)		10,258
Agency discount notes	185		—		(1)		184
Total securities	$	289,645	$	854	$	(370)	$	290,129

whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of June 28, 2025, the Company does not consider any of its investments to be impaired.

The ~~Company~~following ~~typically~~table ~~invests~~is ina ~~highly-rated~~summary ~~securities with original maturities generally ranging from one to three years. The Company's specifically identified gross unrealized losses~~ of ~~$0.4~~available-for-sale ~~million related to~~ securities ~~with total amortized costs of approximately $90.0 million~~ at ~~December~~March 2829, ~~2024. Securities~~2025 (in a continuous unrealized loss position for more than 12 months as of December 28, 2024 had an aggregate amortized cost of $4.3 million and an immaterial amount of aggregate unrealized loss. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management. The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of December 28, 2024, the Company does not consider any of its investments to be impaired.thousands):

The following table is a summary of available-for-sale securities at March 30, 2024 (in thousands):


As of March 29, 2025	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value (Net Carrying Amount)
Corporate debt securities	$	284,885	1,635		$	(55)	$	286,465

U.S. Treasury securities	8,689		45		(3)		8,731



Total securities	$	293,574	$	1,680	$	(58)	$	295,196

As of March 30, 2024	AmortizedCost		GrossUnrealizedGains		GrossUnrealizedLosses		EstimatedFair Value(Net CarryingAmount)
Corporate debt securities	$	186,194	$	115	$	(916)	$	185,393
U.S. Treasury securities	9,850		—		(81)		9,769
Agency discount notes	1,135		—		(11)		1,124
Commercial paper	866		—		—		866
Total securities	$	198,045	$	115	$	(1,008)	$	197,152

The Company's specifically identified gross unrealized losses of $0.1 million related to securities with total amortized costs of approximately $29.8 million at March 29, 2025. Securities in a continuous unrealized loss position for more than 12 months as of March 29, 2025 had an aggregate amortized cost of $1.9 million and an immaterial aggregate unrealized loss. As of March 29, 2025, the Company did not consider any of its investments to be impaired.

The Company's specifically identified gross unrealized losses of $1.0 million related to securities with total amortized costs of approximately $172.1 million at March 30, 2024. Securities in a continuous unrealized loss position for more than 12 months as of March 30, 2024 had an aggregate amortized cost of $25.0 million and an aggregate unrealized loss of $0.3 million. As of March 30, 2024, the Company did not consider any of its investments to be impaired.

The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):

December 28, 2024

March 30, 2024

June 28, 2025

March 29, 2025

Amortized

Estimated

Amortized

Estimated

Cost

Fair Value

Cost

Fair Value

Within 1 year

3765,~~490~~729

3765,~~535~~925

2456,~~071~~044

2356,~~778~~160

After 1 year

~~252~~231,~~155~~291

~~252~~232,~~594~~959

~~173~~237,~~974~~530

~~173~~239,~~374~~036

Total

~~289~~297,~~645~~020

~~290~~298,~~129~~884

~~198~~293,~~045~~574

~~197~~295,~~152~~196

4. Fair Value of Financial Instruments

The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

•Level 1 - Quoted prices in active markets for identical assets or liabilities.

•Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt securities, U.S Treasury securities, securities of U.S. government-sponsored enterprises, and commercial paper and are reflected on our Consolidated Condensed Balance Sheets under the headings cash and cash equivalents, marketable securities, and long-term marketable securities. The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.

The Company's long-term revolving credit facility, described in Note 8 - Revolving Credit Facility, bears interest at a base rate plus applicable margin or forward-looking secured overnight financing rate ("Term SOFR") plus 10 basis points plus applicable margin. As of ~~December~~June 28, ~~2024~~2025, there are no amounts drawn under the facility and the fair value is zero.

As of December 28, 2024 and March 30, 2024, the Company has no Level 3 assets or liabilities. There were no transfers between Level 1, Level 2, or Level 3 measurements for the three months ended December 28, 2024. 9

~~The~~As ~~following~~of June 28, ~~summarizes~~2025 and March 29, 2025, the ~~fair~~Company ~~value~~has ofno ~~our~~Level ~~financial~~3 ~~instruments~~assets ator ~~December 28~~liabilities. There were no transfers between Level 1, ~~2024~~Level ~~(in~~2, ~~thousands):~~or Level 3 measurements for the three months ended June 28, 2025.

	Quoted Pricesin ActiveMarkets forIdenticalAssetsLevel 1		SignificantOtherObservableInputsLevel 2		SignificantUnobservableInputsLevel 3		Total
Assets:
Cash equivalents
Money market funds	$	477,510	$	—	$	—	$	477,510
Available-for-sale securities
Corporate debt securities	$	—	$	279,687	$	—	$	279,687
U.S. Treasury securities	10,258		—		—		10,258
Agency discount notes	—		184		—		184
	$	10,258	$	279,871	$	—	$	290,129

The following summarizes the fair value of our financial instruments at June 28, 2025 (in thousands):


	Quoted Prices in Active Markets for Identical Assets Level 1		Significant Other Observable Inputs Level 2		Significant Unobservable Inputs Level 3		Total
Assets:
Cash equivalents
Money market funds	$	500,160	$	—	$	—	$	500,160



Available-for-sale securities
Corporate debt securities	$	—	$	290,165	$	—	$	290,165

U.S. Treasury securities	8,719		—		—		8,719



	$	8,719	$	290,165	$	—	$	298,884

The following summarizes the fair value of our financial instruments at March 3029, ~~2024~~2025 (in thousands):

	Quoted Pricesin ActiveMarkets forIdenticalAssetsLevel 1		SignificantOtherObservableInputsLevel 2		SignificantUnobservableInputsLevel 3		Total
Assets:
Cash equivalents
Money market funds	$491,467	~~439,065~~	$—	—	$—	—	$491,467	~~439,065~~
Certificates of deposit	—		400		—		400
	$	439,065	$	400	$	—	$	439,465
Available-for-sale securities
Corporate debt securities	$	—	$	~~185~~286,~~393~~465	$	—	$	~~185~~286,~~393~~465
U.S. Treasury securities	98,~~769~~731		—		—		98,~~769~~731
Agency discount notes	—		1,124		—		1,124
	$	8,731	$	286,465	$	—	$	295,196
Commercial paper	—		866		—		866
	$	9,769	$	187,383	$	—	$	197,152

5. Derivative Financial Instruments

Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. The Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on the remeasurement of non-functional currency assets and liabilities within "Other income (expense)" in the Consolidated Condensed Statements of Income. The Company does not apply hedge accounting to these foreign currency derivative instruments.

As of ~~December~~June 28, ~~2024~~2025, the Company held one foreign currency forward contract denominated in British Pound Sterling with a notional value of $22.37 million. The fair value of this contract was not material as of ~~December~~June 28, ~~2024~~2025.

The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands):

	Three Months Ended				~~Nine Months Ended~~
	December 28,		December 30,		December 28,		December 30,
	June 28,		June 29,
	2024		2023		2024		2023		Location
	2025		2024						Location
Gain (loss) recognized in income:
Foreign currency forward contracts	$	(1,~~220)~~164	$	88(32)	$	~~(568)~~	$	~~(384)~~	Other income (expense)

6. Accounts Receivable, net

The following are the components of accounts receivable, net (in thousands):

	December 28,		March 30,
	June 28,		March 29,
	2024		2024
	2025		2025
Gross accounts receivable	$	~~261~~214,~~943~~085	$	~~162~~216,~~478~~009
Allowance for doubtful accounts	—		—
Accounts receivable, net	$	~~261~~214,~~943~~085	$	~~162~~216,~~478~~009

The increase in accounts receivable is due to normal variations in the timing of collections and billings.

7. Inventories

Inventories are comprised of the following (in thousands):

	December 28,		March 30,
	June 28,		March 29,
	2024		2024
	2025		2025
Work in process	$	~~179~~189,~~262~~990	$	~~130~~216,~~842~~173
Finished goods	9688,~~296~~994		9682,~~406~~919
	$	~~275~~278,~~558~~984	$	~~227~~299,~~248~~092

8. Revolving Credit Facility

On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the "Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.

On March 20, 2023, the Company, entered into the First Amendment (the "Amendment") to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative agent. The Amendment updates the benchmark interest rate provisions to replace the London interbank offered rate ("LIBOR") with the forward-looking secured overnight financing rate ("Term SOFR"), for the purposes of calculating interest under the terms of the Second Amended Credit Agreement.

Borrowings under the Revolving Credit Facility may bear interest, at Cirrus Logic’s election, at either (a) a base rate plus the applicable margin ("Base Rate Loans") or (b) a Term SOFR rate plus a 10 basis point credit spread adjustment plus the applicable margin. The applicable margin ranges from 0% to 0.75% per annum for Base Rate Loans and 1.00% to 1.75% per annum for SOFR Loans based on the ratio of consolidated funded indebtedness to consolidated EBITDA for the most recently ended period of four consecutive fiscal quarters (the “Consolidated Leverage Ratio”). A Commitment Fee accrues at a rate per annum ranging from 0.175% to 0.275% (based on the Consolidated Leverage Ratio) on the average daily unused portion of the commitment of the lenders.

The Revolving Credit Facility contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness (minus up to $200 million of unrestricted cash and cash equivalents available on such date) to consolidated EBITDA for the prior four consecutive quarters must not be greater than 3.00 to 1.00 (the “Consolidated Net Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive quarters to consolidated interest expense paid or payable in cash for the prior four consecutive quarters must not be less than 3.00 to 1.00 (the “Consolidated Interest Coverage Ratio”). The Second Amended Credit Agreement also contains customary negative covenants limiting the ability of Cirrus Logic or any Subsidiary to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. Further, the Second Amended Credit Agreement contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations.

~~As of December 28, 2024, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.~~11

Ratio”). The Second Amended Credit Agreement also contains customary negative covenants limiting the ability of Cirrus Logic or any Subsidiary to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. Further, the Second Amended Credit Agreement contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations.

As of June 28, 2025, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.

9. Revenues

Disaggregation of revenue

We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal ("HPMS").

Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands).

Three Months Ended

~~Nine Months Ended~~

December 28,

December 30,

December 28,

December 30,

June 28,

June 29,

2024

2023

2024

2023

2025

2024

Audio Products

~~346~~240,~~272~~043

~~378~~218,~~597~~970

~~881,830~~

~~857,258~~

HPMS Products

~~209~~167,~~466~~229

~~240~~155,~~387~~056

~~589,791~~

~~559,805~~

~~555~~407,~~738~~272

~~618~~374,~~984~~026

~~1,471,621~~

~~1,417,063~~

The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):

Three Months Ended

~~Nine Months Ended~~

December 28,

December 30,

December 28,

December 30,

June 28,

June 29,

2024

2023

2024

2023

2025

2024

China

~~373~~189,~~449~~955

~~429~~205,~~240~~708

~~904,899~~

~~899,168~~

United States

54,~~638~~648

95,~~115~~216

~~13,325~~

~~16,157~~

Rest of World

~~176~~212,~~651~~669

~~180~~163,~~629~~102

~~553,397~~

~~501,738~~

~~555~~407,~~738~~272

~~618~~374,~~984~~026

~~1,471,621~~

~~1,417,063~~

10. ~~Restructuring~~Income ~~Costs~~Taxes

In fiscal year 2023, the Company decided to abandon or sublease office space at various properties worldwide to align our real property lease arrangements with our anticipated operating needs. In addition, in fiscal year 2024, the Company announced a workforce reduction of approximately 5% of its global employees. The Company incurred associated severance and other related charges of $2.3 million in the second quarter of fiscal year 2024. In the third quarter of fiscal year 2024, a recovery of restructuring costs of $0.4 million was recorded for the settlement of certain lease obligations related to abandoned office space associated with the fiscal year 2023 restructuring event. As of December 28, 2024, remaining restructuring-related liabilities were immaterial and are expected to be substantially paid out in cash during fiscal year 2025.

11. Income Taxes

Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items, and any applicable income tax credits.

The following table presents the provision for income taxes (in thousands) and the effective tax rates:

	Three Months Ended						~~Nine Months Ended~~
	December 28,			December 30,			December 28,			December 30,
	June 28,			June 29,
	2024			2023			2024			2023
	2025			2024
Income before income taxes	$	~~153~~80,~~701~~628		$	~~172~~56,~~100~~603		$	~~350,309~~		$	~~304,278~~
Provision for income taxes	$	3719,~~696~~931		$	3314,~~377~~508		$	~~90,069~~		$	~~74,548~~
Effective tax rate	24.57		%	1925.46		%	~~25.7~~		%	~~24.5~~		%

Our income tax expense was $~~37.7 million and $33.4 million for the third quarters of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 24.5 percent and~~ 19.49 ~~percent, respectively. Our income tax expense was $90.1~~ million and $7414.5 million for the first ~~nine~~quarters ~~months~~ of fiscal years ~~2025~~2026 and ~~2024~~2025, respectively, resulting in effective tax rates of 2524.7 percent and 2425.56 percent, respectively.

Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires research and development ("R&D") expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, resulting in higher global intangible low-taxed income ("GILTI"), which is treated as a period cost. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, 12

13Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires research and development ("R&D") expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI.

~~including~~On ~~R&D~~July ~~expenditure~~4, ~~credits available to us in the United Kingdom~~2025, ~~that reduce~~ the ~~amount~~One ofBig ~~foreign~~Beautiful ~~tax~~Bill ~~credits~~Act ~~available~~("OBBBA") towas ~~offset~~signed ~~GILTI~~into law. ~~Our~~The ~~effective~~OBBBA ~~tax~~includes ~~rates~~a ~~for~~broad ~~the~~range ~~third quarter~~ of ~~fiscal~~tax ~~year~~reform ~~2025~~provisions, ~~and~~including the ~~first~~permanent ~~nine~~elimination ~~months~~ of ~~fiscal~~the ~~years~~requirement ~~2025~~to capitalize and ~~2024,~~amortize ~~respectively,~~U.S. ~~were~~R&D ~~higher~~expenditures, ~~than~~modifications ~~the federal statutory rate primarily due~~ to ~~these~~international ~~two~~tax ~~items~~provisions, ~~partially~~and ~~offset by~~ the ~~effect~~permanent extension of ~~income~~certain ~~earned~~expiring inprovisions ~~certain~~initially ~~foreign~~established ~~jurisdictions~~by ~~that~~the isTax ~~taxed~~Cuts ~~below~~and ~~the~~Jobs ~~federal~~Act ~~statutory~~of ~~rate~~2017. ~~Our~~The OBBBA has multiple effective ~~rate~~dates, ~~for~~with ~~the~~certain ~~third~~provisions ~~quarter~~effective ofin fiscal year ~~2024~~2026 ~~was~~and ~~lower~~others ~~than~~effective ~~the~~in ~~federal~~fiscal ~~statutory~~year ~~rate~~2027. We ~~due~~are toassessing athe ~~one-time~~legislation ~~tax~~and ~~benefit~~its ~~recorded~~effect ~~during~~on ~~that~~our ~~period~~consolidated ~~for~~financial astatements, ~~change~~which inwe ~~capitalized~~expect ~~R&D~~to ~~expenditures~~begin ~~that~~reflecting ~~decreased~~in ~~GILTI~~the ~~inclusions~~second inquarter ~~our~~of fiscal year ~~2023 U~~2026.~~S. tax return.~~

The Company records unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns. At ~~December~~June 28, ~~2024~~2025, the Company had unrecognized tax benefits of $32.1 million, all of which would impact the effective tax rate if recognized. The Company’s total unrecognized tax benefits are classified as “Non-current income taxes" in the Consolidated Condensed Balance Sheets. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. As of ~~December~~June 28, ~~2024~~2025, the balance of accrued interest and penalties, net of tax, was $1112.36 million.

On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany cost-sharing arrangements were invalid. In 2016 the U.S. Internal Revenue Service appealed the decision to the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). On June 7, 2019, the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations. On February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United States, which was denied by the Supreme Court on June 22, 2020. Although the issue is now resolved in the Ninth Circuit, the Ninth Circuit's opinion is not binding in other circuits. The potential impact of this issue on the Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time. We will continue to monitor developments related to this issue and the potential impact of those developments on the Company's current and prior fiscal years.

The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. Fiscal years 2017 through 2019 and ~~2021~~2022 through ~~2024~~2025 remain open to examination by the major taxing jurisdictions in which the Company operates.

The Company's fiscal year 2017, 2018, and 2019 federal income tax returns are under examination by the U.S. Internal Revenue Service ("IRS"). The IRS has proposed adjustments that would increase U.S. taxable income related to transfer pricing matters with respect to our U.S. and U.K. affiliated companies. The final Revenue Agent’s Report asserted additional tax of approximately $168.3 million, excluding interest, and imposed penalties of approximately $63.7 million. The Company does not agree with the IRS's positions and has not accrued an additional liability. In July 2024, the Company entered the administrative dispute process with the IRS Independent Office of Appeals ("IRS Appeals"). We intend to vigorously dispute the proposed adjustments and pursue judicial remedies if an acceptable outcome cannot be reached with IRS Appeals. The Company expects it could take a number of years to reach resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes adequate amounts have been reserved in accordance with ASC 740 for any adjustments to the provision for income taxes that may ultimately result. However, if the IRS prevails in these matters, the ultimate amount of assessed tax, interest, and penalties, if any, could be material and may have an adverse impact on our financial position, results of operations, and cash flows in future periods. The Company is not under an income tax audit in any other major taxing jurisdiction.

~~12. Net Income Per Share~~13

11. Net Income Per Share

Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding. These potentially dilutive items consist primarily of outstanding stock options and restricted stock units.

14The following table details the calculation of basic and diluted earnings per share for the three months ended June 28, 2025 and June 29, 2024 (in thousands, except per share amounts):

The following table details the calculation of basic and diluted earnings per share for the three and nine months ended December 28, 2024 and December 30, 2023 (in thousands, except per share amounts):


	Three Months Ended
	June 28,		June 29,
	2025		2024
Numerator:
Net income	$	60,697	$	42,095
Denominator:
Weighted average shares outstanding	51,727		53,433
Effect of dilutive securities	1,592		2,232
Weighted average diluted shares	53,319		55,665
Basic earnings per share	$	1.17	$	0.79
Diluted earnings per share	$	1.14	$	0.76

	Three Months Ended				Nine Months Ended
	December 28,		December 30,		December 28,		December 30,
	2024		2023		2024		2023
Numerator:
Net income	$	116,005	$	138,723	$	260,240	$	229,730
Denominator:
Weighted average shares outstanding	53,081		54,016		53,263		54,449
Effect of dilutive securities	1,995		1,576		2,266		1,711
Weighted average diluted shares	55,076		55,592		55,529		56,160
Basic earnings per share	$	2.19	$	2.57	$	4.89	$	4.22
Diluted earnings per share	$	2.11	$	2.50	$	4.69	$	4.09

The weighted outstanding shares excluded from our diluted calculation for the three months ended June 28, 2025 and June 29, 2024 were 253 thousand and 259 thousand, respectively, as the shares were anti-dilutive.

The weighted outstanding shares excluded from our diluted calculation for the three and nine months ended December 28, 2024 were 228 thousand and 224 thousand, respectively, as the shares were anti-dilutive12. ~~The~~ ~~weighted~~Commitments ~~outstanding shares excluded from our diluted calculation for the three~~ and ~~nine months ended December 30, 2023 were 388 thousand and 394 thousand, respectively, as the shares were anti-dilutive.~~Contingencies

13. Commitments and Contingencies

Capacity Reservation Agreement

On July 28, 2021, the Company entered into a Capacity Reservation and Wafer Supply Commitment Agreement (the “Capacity Reservation Agreement”) with GlobalFoundries to provide the Company a wafer capacity commitment and wafer pricing for Company products for calendar years 2022-2026 (the “Commitment Period”). On February 18, 2025, the Capacity Reservation Agreement was amended (the "Amendment") to define the quarterly spread of the remaining wafer quantities under the agreement.

The Capacity Reservation Agreement requires GlobalFoundries to provide, and the Company to purchase, a defined number of wafers on a quarterly basis for the Commitment Period, subject to shortfall payments. In exchange for GlobalFoundries’ capacity commitment, the Company paid a $60 million non-refundable capacity reservation fee, which is amortized over the Commitment Period. The balance of this reservation fee is $2015 million as of ~~December~~June 28, ~~2024~~2025, and is recorded in "Other current assets" and "Other assets" on the Consolidated Condensed Balance Sheets within the short-term or long-term classification, as appropriate. In addition, the Company pre-paid GlobalFoundries $195 million for future wafer purchases, which are credited back to the Company as a portion of the price of wafers purchased, which began in the Company's second fiscal quarter of 2024. The balance of the prepayment is $8962 million at ~~December~~June 28, ~~2024~~2025, and is currently recorded in "~~Long-term prepaid wafers" and "~~Prepaid wafers" on the Consolidated Condensed Balance Sheets.

1413. Legal Matters

From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities. We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred, and to determine if accruals are appropriate. We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made.

Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows. However, we are engaged in various legal actions in the normal course of business. There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.

1514. Stockholders' Equity

15. Stockholders' Equity

Common Stock

The Company issued aan ~~net~~immaterial ~~0.7 million~~amount and 1.0.2 million of shares of common stock during ~~each of~~ the three ~~and nine~~ months ended ~~December~~June 28, ~~2024,~~2025 and ~~issued a net 0.5 million and 0.6 million of shares of common stock for the three and nine~~June ~~months~~29, ~~ended~~2024, ~~December 30~~respectively, ~~2023~~ pursuant to the Company's equity incentive plans.

Share Repurchase Program

The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, which is included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity. As of ~~December~~June 28, ~~2024~~2025, ~~the Company has accrued~~ approximately $02.53 million is accrued related to this excise tax. Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.

In July 2022, the Board of Directors authorized the repurchase of up to $500 million of the Company's common stock. As ofDuring ~~December~~the three months ended June 28, ~~2024~~2025, ~~approximately~~the ~~$345.9~~Company ~~million~~completed ofshare repurchases under the ~~Company's~~2022 ~~common~~authorization. In ~~stock~~March ~~has~~2025, ~~been~~the ~~repurchased~~Board ~~under~~of ~~the~~Directors ~~share~~authorized the repurchase ~~authorization,~~of ~~leaving~~up ~~approximately~~to $~~154.1~~500 million ~~available~~of ~~for repurchase. During~~ the ~~three~~Company's ~~months~~common ~~ended~~stock. As ~~December~~of June 28, ~~2024~~2025, ~~the~~approximately ~~Company repurchased 0~~$45.7 9 million ~~shares~~ of the Company's common stock ~~for~~has ~~$70.0~~been ~~million,~~repurchased atunder anthe ~~average~~share ~~cost~~repurchase ofauthorization, leaving approximately $~~103~~454.181 ~~per~~million ~~share~~available for repurchase under the 2025 authorization. During the ~~nine~~three months ended ~~December~~June 28, ~~2024~~2025, the Company repurchased 1.40 million shares of the Company's common stock for $~~161~~100.0 million, at an average cost of $~~115~~98.3166 per share under the combined share authorizations.

1615. Segment Information

We determine our operating segments in accordance with FASB guidelines. Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker ("CODM") under these guidelines.

The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and HPMS. Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources~~, rather than detailed information at a product line level~~. ~~Additionally,~~ Our ~~our~~ product lines have similar characteristics and customers~~. They~~ and share operations support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology. Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.

The CODM evaluates Company performance based on net income, and this information is used to measure profitability, make budgeting and forecasting decisions, monitor performance trends, and to compare actual results to forecasts. The CODM regularly reviews the consolidated statement of income and a disaggregation of operating expenses, with a focus on personnel-related and product development expenses. The measure of segment assets is reported on the balance sheet as total consolidated assets.

The table below presents the Company's significant segment operating expenses (in thousands):


	Three Months Ended
	June 28, 2025		June 29, 2024
Personnel-related (1)	$	88,318	$	84,501
Product development (2)	13,731		14,916
Other segment items (3)	39,587		42,716
Total Operating Expense	$	141,636	$	142,133

(1) Personnel-related expenses include employee base pay, benefits, variable compensation and other employee-related expenses.

(2) Product development costs include software, engineering mask sets, wafers, and boards, as well as outside design services.

(3) Other segment items primarily include stock-based compensation, facilities-related costs, depreciation and amortization, and non-recurring charges, offset by the benefit received from research and development expenditure credits.

Geographic Area

The Company's geographic details of revenue are included below.

The following illustrates net sales by ship to location of the customer (in thousands):


	Three Months Ended
	June 28, 2025		June 29, 2024
China	$	189,955	$	205,708
India	75,429		38,032
Hong Kong	49,175		41,649
Vietnam	36,263		26,283
South Korea	32,893		38,883
United States	4,648		5,216
Rest of World	18,909		18,255
Total consolidated sales	$	407,272	$	374,026

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read along with the unaudited consolidated condensed financial statements and notes thereto included in Item 1 of this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the fiscal year ended March 3029, ~~2024~~2025, contained in our fiscal year ~~2024~~2025 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “Commission”) on May 2423, ~~2024~~2025. We maintain a website at investor.cirrus.com, which makes available free of charge our most recent annual report and all other filings we have made with the Commission.

Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q including Management’s Discussion and Analysis of Financial Condition and Results of Operations and certain information incorporated herein by reference contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These forward-looking statements are based on expectations, estimates, forecasts and projections and the beliefs and assumptions of our management as of the filing of this Form 10-Q. In some cases, forward-looking statements are identified by words such as “expect,” “anticipate,” “target,” “project,” “believe,” “goals,” “estimates,” “intend,” and variations of these types of words and similar expressions which are intended to identify these forward-looking statements. In addition, any statements that refer to our plans, expectations, strategies or other characterizations of future events or circumstances are forward-looking statements. Readers are cautioned that these forward-looking statements are predictions and are subject to risks, uncertainties and assumptions that are difficult to

strategies or other characterizations of future events or circumstances are forward-looking statements. Readers are cautioned that these forward-looking statements are predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements and readers should not place undue reliance on such statements. We undertake no obligation, and expressly disclaim any duty, to revise or update publicly any forward-looking statement for any reason.

For additional information regarding known material factors that could cause our actual results to differ from our projected results, please see “Item 1A - Risk Factors” in our ~~2024~~2025 Annual Report on Form 10-K filed with the Commission on May 2423, ~~2024~~2025, and in "Part II, Item 1A - Risk Factors” within this Quarterly Report on Form 10-Q. Readers should carefully review these risk factors, as well as those identified in other documents filed by us with the Commission.

Overview

Cirrus Logic, Inc. (“Cirrus Logic,” “We,” “Us,” “Our,” or the “Company”) is a leader in low-power, high-precision mixed-signal processing solutions that create innovative user experiences for the world’s top mobile and consumer applications.

The Company remains committed to our three-pronged strategy for growing our business: first, maintaining our leadership position in smartphone audio; second, increasing HPMS content in smartphones; and third, leveraging our strength in audio and HPMS to expand into additional applications and markets with new and existing components. During the ~~third~~first quarter of fiscal year ~~2025~~2026, we continued to execute on these strategic initiatives. We ~~saw~~were ~~strong~~delighted ~~demand~~with ~~for~~the ~~products~~success ~~shipping~~of ~~into~~our ~~smartphones~~latest-generation smartphone audio components, including our ~~latest-generation~~ custom boosted amplifier and ~~our~~ first 22-nanometer smart codec,. ~~and~~Outside of smartphones, we continued to gain ~~momentum~~traction in ~~laptops~~the laptop market. ~~Recent~~In ~~highlights~~the inJune quarter, our PCnext-~~focused~~generation ~~business~~amplifier ~~include~~and ~~being~~codec ~~featured~~were asdesigned ~~part~~into ofseveral ~~the~~new ~~Intel~~laptops, ~~Arrow~~we ~~Lake~~announced ~~reference~~a ~~design~~collaboration with Compal to address persistent audio quality challenges, ~~sampling~~and we continued development on multiple new laptop components. Progress in our ~~latest~~general ~~amplifier~~market ~~and~~business, ~~codec~~which ~~specifically~~spans ~~designed~~the ~~for~~professional ~~laptops~~audio, automotive, industrial, and ~~expanding~~imaging ~~the~~end ~~breadth~~markets, included ramping production of ~~content~~our ~~across~~latest-generation aanalog-to-digital ~~variety~~converters of(ADCs), ~~new~~digital-to-analog ~~devices~~converters (DACs), and an ultra-high-performance audio codec. Finally, we also began ~~sampling~~shipping aour ~~series~~recently-introduced of timing ~~products~~product ~~designed~~to ~~for~~an automotive ~~and professional audio applications~~customer.

Critical Accounting Policies and Estimates

Our discussion and analysis of the Company’s financial condition and results of operations are based upon the unaudited consolidated condensed financial statements included in this report, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts. We evaluate the estimates on an ongoing basis. We base these estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions.

There have been no significant changes during the three ~~and nine~~ months ended ~~December~~June 28, ~~2024~~2025, to the information provided under the headings “Critical Accounting Estimates” and "Summary of Significant Accounting Policies" included in our fiscal year ~~2024~~2025 Annual Report on Form 10-K for the fiscal year ended March 3029, ~~2024~~2025.

Recently Issued Accounting Pronouncements

For a discussion of recently issued accounting pronouncements, refer to Note 2 of the Notes to the Consolidated Condensed Financial Statements.

Results of Operations

Our fiscal year is the 52- or 53-week period ending on the last Saturday in March. Fiscal ~~year~~years ~~2025~~2026 isand a2025 are 52-week fiscal ~~year~~years. Fiscal year 2024 was a 53-week fiscal year, including a 14-week fiscal third quarter. Therefore, the three and nine month periods ended December 30, 2023 included an additional week, as compared to the current fiscal year 2025 periods.

The following table summarizes the results of our operations for the three months of fiscal years 2026 and 2025, respectively, as a percentage of net sales. All percentage amounts were calculated using the underlying data in thousands, unaudited:

The following table summarizes the results of our operations for the three and nine months of fiscal years 2025 and 2024, respectively, as a percentage of net sales. All percentage amounts were calculated using the underlying data in thousands, unaudited:


	Three Months Ended
	June 28,		June 29,
	2025		2024
Net sales	100	%	100	%
Gross margin	53	%	51	%
Research and development	25	%	28	%
Selling, general and administrative	10	%	10	%


Income from operations	18	%	13	%
Interest income	2	%	2	%
Interest expense	—	%	—	%
Other income (expense)	—	%	—	%
Income before income taxes	20	%	15	%
Provision for income taxes	5	%	4	%
Net income	15	%	11	%

	Three Months Ended				Nine Months Ended
	December 28,		December 30,		December 28,		December 30,
	2024		2023		2024		2023
Net sales	100	%	100	%	100	%	100	%
Gross margin	54	%	51	%	52	%	51	%
Research and development	20	%	18	%	22	%	23	%
Selling, general and administrative	7	%	6	%	8	%	8	%
Restructuring costs	—	%	—	%	—	%	—	%
Income from operations	26	%	27	%	22	%	20	%
Interest income	2	%	1	%	2	%	1	%
Interest expense	—	%	—	%	—	%	—	%
Other income (expense)	—	%	—	%	—	%	—	%
Income before income taxes	28	%	28	%	24	%	21	%
Provision for income taxes	7	%	5	%	6	%	5	%
Net income	21	%	23	%	18	%	16	%

Net Sales

Net sales for the ~~third~~first quarter of fiscal year ~~2025~~2026 ~~decreased~~increased $6333.2 million, or 109 percent, to $~~555~~407.73 million from $~~619~~374.0 million in the ~~third~~first quarter of fiscal year ~~2024~~2025. Net sales from our audio products ~~decreased~~increased $3221.31 million, primarily driven by ~~lower~~sales ~~smartphone~~associated ~~unit~~with ~~volumes~~latest-generation inproducts ~~the~~and ~~third~~higher ~~quarter~~smartphone ofunit ~~fiscal~~volumes ~~year 2025, due~~ in ~~part to~~ the ~~third~~first quarter of fiscal year ~~2024 encompassing one week more of the higher-volume production associated with typical seasonal product ramps and the additional week of revenue as part of a 53-week fiscal year~~2026. ~~This decrease was partially offset by increased revenue associated with latest-generation products.~~ Net sales from HPMS products ~~decreased~~increased $3012.92 million for the quarter versus the ~~third~~first quarter of fiscal year ~~2024~~2025, primarily due to ~~lower~~higher smartphone unit volumes, ~~partially~~and ~~offset~~sales ~~by revenue~~ associated with latest-generation products.

~~Net~~International sales ~~for the first nine months of fiscal year 2025 increased $54.6 million~~, orincluding 4sales ~~percent,~~ to $1U.~~5 billion from $1~~S.4-based ~~billion~~end ~~for~~customers ~~the~~that ~~first~~manufacture ~~nine months of fiscal year 2024. Net sales from our audio~~ products ~~increased~~through ~~$24.6~~contract ~~million,~~manufacturers ~~primarily~~or ~~driven~~plants bylocated ~~sales associated with latest-generation products and higher smartphone unit volumes~~overseas, ~~partially~~were ~~offset~~approximately by99 ~~lower~~percent ~~general~~of ~~market~~net sales~~. Net~~ ~~sales from HPMS products increased $30.0 million~~ for the ~~year versus the~~ first ~~nine~~quarters ~~months~~ of fiscal ~~year~~years ~~2024,~~2026 ~~primarily due to higher content in smartphones~~ and 2025. Our sales ~~associated~~are ~~with~~denominated ~~latest-generation~~primarily ~~products,~~in ~~partially~~U.S. ~~offset by lower general market sales~~dollars.

~~International~~Since ~~sales~~the components we produce are largely proprietary, ~~including~~we ~~sales~~consider our end customer to Ube the entity specifying the use of our component in their design.~~S.-based~~ These end customers ~~that~~may ~~manufacture~~purchase our products ~~through~~directly ~~contract~~from ~~manufacturers~~us, orthrough ~~plants located overseas~~distributors, ~~were~~or ~~approximately~~third-party 99manufacturers ~~percent~~contracted ofto ~~net~~produce ~~sales~~their ~~for~~designs. For the ~~third~~first ~~quarters~~quarter of fiscal years ~~2025~~2026 and ~~2024~~2025, ~~and~~our ~~for~~ten ~~each~~largest ofend ~~the~~customers ~~first~~represented ~~nine~~approximately ~~month~~95 ~~periods~~percent ofand ~~fiscal~~96 ~~years~~percent, ~~2025~~of ~~and~~our ~~2024. Our~~net sales, ~~are denominated primarily in U~~respectively.~~S. dollars.~~

~~Since~~We ~~the~~had ~~components~~one ~~we produce are largely proprietary, we consider our~~ end customer, toApple ~~be the entity specifying the use of our component in their design~~Inc. ~~These~~, ~~end~~that ~~customers~~purchased ~~may purchase our products directly from us,~~ through ~~distributors,~~multiple orcontract ~~third-party~~ manufacturers ~~contracted to produce their designs. For each of the third quarters of fiscal years 2025~~ and ~~2024, our ten largest end customers~~ represented approximately 9686 percent, ~~of our net sales,~~ and 9688 percent ~~and~~of 95the ~~percent~~Company’s oftotal ~~our~~ net sales for the first quarter ~~nine months~~ of fiscal years ~~2025~~2026 and ~~2024~~2025, respectively.

WeNo ~~had~~other ~~one~~ end customer, ~~Apple~~or ~~Inc.,~~distributor ~~that purchased through multiple contract manufacturers and~~ represented ~~approximately~~more 91than ~~percent~~10 ~~and 89~~ percent of ~~the Company’s total~~ net sales for the ~~third quarter~~three ofmonths ~~fiscal~~ended ~~years 2025 and 2024~~June 28, ~~respectively, and 90 percent and 87 percent for the first nine months of fiscal years~~ 2025 ~~and~~or ~~2024~~June 29, ~~respectively~~2024.

No other end customer or distributor represented more than 10 percent of net sales for the three and nine months ended December 28, 2024 or December 30, 2023.

For more information, please see "Part II, Item 1A - Risk Factors" — “We depend on a limited number of customers and distributors for a substantial portion of our sales, and the loss of, or a significant reduction in orders from, or pricing on products sold to, any key customer or distributor could significantly reduce our sales and our profitability.”

Gross Margin

Gross margin was 5352.6 percent in the ~~third~~first quarter of fiscal year ~~2025~~2026, up from 5150.35 percent in the ~~third~~first quarter of fiscal year ~~2024~~2025, largely due to a ~~shift~~more infavorable ~~mix~~product ~~toward higher margin products, partially offset by higher inventory reserves and supply chain costs~~mix.

Gross margin was 52.3 percent for the first nine months of fiscal year 2025, up from 51.1 percent for the first nine months of fiscal year 2024 due to a shift in mix toward higher margin products and, to a lesser extent, favorable freight costs, partially offset by higher inventory reserves and supply chain costs.

Research and Development Expense

Research and development expense for the ~~third~~first quarter of fiscal year ~~2025~~2026 was $~~113~~102.09 million, ana ~~increase~~decrease of $02.35 million, from $~~112~~105.74 million in the ~~third~~first quarter of fiscal year ~~2024~~2025. Significant drivers included ~~increased~~reduced ~~employee~~stock-~~related~~based compensation and product development costs, partially offset by ~~reduced~~increased ~~stock~~employee-~~based~~related ~~compensation~~ costs ~~and increased R&D incentives~~ in the current quarter.

Research and development expense for the first nine months of fiscal year 2025 was $331.3 million, an increase of $8.2 million, from $323.1 million for the first nine months of fiscal year 2024 primarily due to increased employee-related, variable compensation, and facilities-related costs, partially offset by reduced acquisition-related costs, stock-based compensation, increased R&D incentives, and an investment write-off that occurred in the first quarter of fiscal year 2024.18

Selling, General and Administrative Expense

Selling, general and administrative expense for the ~~third~~first quarter of fiscal year ~~2025~~2026 was $3938.07 million, an increase of $12.40 million, from $3736.68 million in the ~~third~~first quarter of fiscal year ~~2024~~2025, due primarily to increased stock-based compensation and employee-related expenses. The increase was partially offset by the absence in the first quarter of fiscal year 2026 of lease impairment costs incurred during the first quarter of fiscal year 2025, related to refined sublease assumptions for previously vacated office space.

Selling, general and administrative expense for the first nine months of fiscal year 2025 was $113.6 million, an increase of $6.3 million, from $107.3 million for the first nine months of fiscal year 2024, primarily due to increased employee-related expenses, variable compensation costs, and lease impairment and settlement activity for the period.

Restructuring Costs

Restructuring costs (recoveries) for the third quarter and first nine months of fiscal year 2024 were $(0.4) million and $2.0 million, respectively. These costs were primarily related to the facilities restructuring and workforce reduction actions previously disclosed. See Note 10 - Restructuring Costs for additional information.

Interest Income

The Company reported interest income of $8.48 million and $258.24 million for the three ~~and nine~~ months ended ~~December~~June 28, ~~2024,~~2025 ~~respectively,~~ and ~~$5.1 million and $13.9 million for the three and nine months ended December~~June 3029, ~~2023~~2024, respectively. Interest income increased in the current period due to ~~higher~~returns ~~yields~~generated onfrom higher combined average cash, cash equivalents and marketable securities balances, compared to the prior period.

Interest Expense

The Company reported interest expense of $0.2 million and $0.72 million for the three ~~and nine~~ months ended ~~December~~June 28, ~~2024,~~2025 ~~respectively,~~ and ~~$0.2 million and $0.7 million for the three and nine months ended December~~June 3029, ~~2023~~2024, respectively. Interest expense consists primarily of commitment fees associated with the Company's Revolving Credit Facility (see Note 8 - Revolving Credit Facility of the Notes to the Consolidated Condensed Financial Statements).

Other Income (Expense)

For the three ~~and nine~~ months ended ~~December~~June 28, 2025 and June 29, 2024, the Company reported other expense of $0.24 million and $1.46 million in other income, respectively~~, and $0~~.3 This ~~million~~activity ~~and~~primarily anrelated ~~immaterial~~to ~~amount~~non-investment ofrelated ~~other~~income (expense) ~~for~~and ~~the~~remeasurement ~~three~~on ~~and~~foreign ~~nine~~currency denominated monetary assets and liabilities.

months ended December 30, 2023, respectively. This activity primarily related to non-investment related income and remeasurement on foreign currency denominated monetary assets and liabilities.

Income Taxes

The following table presents the provision for income taxes (in thousands) and the effective tax rates:

	Three Months Ended						~~Nine Months Ended~~
	December 28,			December 30,			December 28,			December 30,
	June 28,			June 29,
	2024			2023			2024			2023
	2025			2024
Income before income taxes	$	~~153~~80,~~701~~628		$	~~172~~56,~~100~~603		$	~~350,309~~		$	~~304,278~~
Provision for income taxes	$	3719,~~696~~931		$	3314,~~377~~508		$	~~90,069~~		$	~~74,548~~
Effective tax rate	24.57		%	1925.46		%	~~25.7~~		%	~~24.5~~		%

Our income tax expense for the ~~third~~first quarter of fiscal year ~~2025~~2026 was $3719.79 million compared to $3314.45 million for the ~~third~~first quarter of fiscal year ~~2024~~2025, resulting in effective tax rates of 24.57 percent and ~~19.4 percent, respectively. Our income tax expense was $90.1 million and $74.5 million for the first nine months of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of~~ 25.76 percent ~~and 24.5 percent~~, respectively. Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires R&D expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, resulting in higher GILTI, which is treated as a period cost. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI. Our effective tax rates for the third quarter of fiscal year 2025 and the first nine months of fiscal years 2025 and 2024, respectively, were higher than the federal statutory rate primarily due to these two items, partially offset by the effect of income earned in certain foreign jurisdictions that is taxed below the federal statutory rate. Our effective tax rate for the third quarter of fiscal year 2024 was lower than the federal statutory rate due to a one-time tax benefit recorded during that period for a change in capitalized R&D expenditures that decreased GILTI inclusions in our fiscal year 2023 U.S. tax return.

Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires research and development ("R&D") expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law. The OBBBA includes a broad range of tax reform provisions, including the permanent elimination of the requirement to capitalize and amortize U.S. R&D expenditures, modifications to international tax provisions, and the permanent extension of certain expiring provisions initially established by the Tax Cuts and Jobs Act of 2017. The OBBBA has multiple effective dates, with certain provisions effective in fiscal year 2026 and others effective in fiscal year 2027. We are assessing the legislation and its effect on our consolidated financial statements, which we expect to begin reflecting in the second quarter of fiscal year 2026.

Liquidity and Capital Resources

We require cash to fund our operating expenses and working capital requirements, including outlays for inventory, capital expenditures, share repurchases, and strategic acquisitions. Our principal sources of liquidity are cash on hand, cash generated from operations, cash generated from the sale and maturity of marketable securities, and available borrowings under our $300 million Revolving Credit Facility.

Cash generated from our operating activities is net income adjusted for certain non-cash items and changes in working capital. Cash generated from operations was $~~314~~116.01 million for the first ~~nine~~three months of fiscal year ~~2025~~2026 versus $~~251~~87.12 million generated for the corresponding period of fiscal year ~~2024~~2025. The cash flow from operations during the first ~~nine~~three months of fiscal year ~~2025~~2026 was related to the cash components of our net income and a $5727.4 million ~~unfavorable~~favorable change in working capital, primarily as a result of ~~increases~~decreases in ~~accounts receivables and~~ inventory, ~~partially offset by~~ increases in prepaid wafer usage (related to the Capacity Reservation Agreement), and income taxes payable, ~~and~~partially offset by decreases in accounts payable and other accrued liabilities. The cash flow from operations during the corresponding period of fiscal year ~~2024~~2025 was related to the cash components of our net income and ana $8716.41 million ~~unfavorable~~favorable change in working capital, primarily as a result of anincreases ~~increase~~ in ~~accounts~~income ~~receivables~~taxes ~~and~~payable, ~~inventory and decreases in~~ accounts payable and other accrued liabilities and ~~acquisition-related liabilities, partially offset by~~ prepaid wafer usage (related to the Capacity Reservation Agreement), ~~beginning~~partially inoffset ~~the~~by ~~second~~increases ~~quarter~~in ofaccounts ~~fiscal year 2024~~receivables.

Net cash used in investing activities was $~~111~~6.2 million during the first ~~nine~~three months of fiscal year ~~2025~~2026 versus $6066.86 million during the first ~~nine~~three months of fiscal year ~~2024~~2025. The cash used in investing activities in the first ~~nine~~three months of fiscal year ~~2025~~2026 was related to net purchases of marketable securities of $913.64 million and capital expenditures and technology investments of $192.68 million. The cash used in investing activities in the corresponding period in fiscal year ~~2024~~2025 was related to net ~~capital~~purchases ~~expenditures~~of ~~and~~marketable ~~technology~~securities ~~investments~~ of $3056.74 million and ~~net~~capital ~~purchases~~expenditures ofand ~~marketable~~technology ~~securities~~investments of $3010.1 million.

20Net cash used in financing activities was $100.7 million during the first three months of fiscal year 2026 and was primarily associated with stock repurchases for the period of $100.0 million. The cash used in financing activities during the first three months of fiscal year 2025 of $32.0 million was primarily associated with stock repurchases during the period of $41.0 million, partially offset by $9.0 million in net proceeds from the issuance of common stock, primarily related to stock option exercises.

~~Net~~Our ~~cash~~future ~~used~~capital inrequirements ~~financing~~will ~~activities~~depend ~~was~~on ~~$179.1~~many ~~million~~factors, ~~during~~including the ~~first~~rate ~~nine~~of ~~months~~sales growth, market acceptance of ~~fiscal~~our ~~year~~products, ~~2025~~the timing and ~~was~~extent ~~primarily~~of ~~associated~~research ~~with~~and ~~stock~~development ~~repurchases~~projects, ~~for~~potential future acquisitions of companies or technologies, inventory build, and commitments under the ~~period~~Capacity Reservation Agreement with GlobalFoundries (discussed further in Note 12 - Commitments and Contingencies of ~~$161.0~~the ~~million~~Notes to the Consolidated Condensed Financial Statements). ~~The~~We believe our expected future cash ~~used~~earnings, existing cash, cash equivalents, investment balances, and available borrowings under our Revolving Credit Facility will be sufficient to meet our capital requirements both domestically and internationally, in ~~financing~~the ~~activities~~short-term ~~during~~(i.e. the ~~first~~next ~~nine~~12 months) ofand ~~fiscal~~in ~~year~~the ~~2024~~long-term, ofalthough ~~$152.2~~we ~~million~~could ~~was~~be ~~primarily~~required, ~~associated~~or ~~with~~could ~~stock~~elect, ~~repurchases~~to ~~during~~seek ~~the~~additional ~~period~~funding ofprior ~~$136.0~~to ~~million~~that time.

Our future capital requirements will depend on many factors, including the rate of sales growth, market acceptance of our products, the timing and extent of research and development projects, potential future acquisitions of companies or technologies, inventory build, and commitments under the Capacity Reservation Agreement with GlobalFoundries (discussed further in Note 13 - Commitments and Contingencies of the Notes to the Consolidated Condensed Financial Statements). We believe our expected future cash earnings, existing cash, cash equivalents, investment balances, and available borrowings under our Revolving Credit Facility will be sufficient to meet our capital requirements both domestically and internationally, in the short-term (i.e. the next 12 months) and in the long-term, although we could be required, or could elect, to seek additional funding prior to that time.

Revolving Credit Facility

On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries ("Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.

On March 20, 2023, the Company, entered into the First Amendment (the "Amendment") to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative agent. The Amendment updates the benchmark interest rate provisions to replace LIBOR with Term SOFR, for the purposes of calculating interest under the terms of the Second Amended Credit Agreement.

As of ~~December~~June 28, ~~2024~~2025, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.

See Note 8 — Revolving Credit Facility of the Notes to the Consolidated Condensed Financial Statements for additional information including material terms and related covenants.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risks associated with interest rates on our debt securities, currency movements on non-functional currency assets and liabilities, and the effect of market factors on the value of our marketable securities. We assess these risks on a regular basis and have established policies that are designed to protect against the adverse effects of these and other potential exposures. We use forward contracts to manage exposure to foreign currency exchange risk attributable to certain non-U.S. dollar balance sheet exposures. Gains and losses from these foreign currency forward contracts are recognized currently in earnings along with the gains and losses resulting from remeasuring the underlying exposures. Information about our market risks as of ~~December~~June 28, ~~2024~~2025, does not materially differ from the description of our market risks included in "Part II – Item 7A – Quantitative and Qualitative Disclosures about Market Risk” within our fiscal year ~~2024~~2025 Annual Report on Form 10-K filed with the Commission on May 2423, ~~2024~~2025. For related financial statement impact see Note 5 - Derivative Financial Instruments of the Notes to the Consolidated Condensed Financial Statements.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

As required by Rule 13a-15(b) of the Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our chief executive officer (CEO) and ~~interim~~ chief financial officer (CFO), the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Commission rules and forms and (ii) accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

21Based upon the evaluation, our management, including our CEO and CFO, has concluded that our disclosure controls and procedures were effective as of June 28, 2025.

Based upon the evaluation, our management, including our CEO and CFO, has concluded that our disclosure controls and procedures were effective as of December 28, 2024.

Changes in control over financial reporting

There has been no change in the Company’s internal control over financial reporting during the quarter ended ~~December~~June 28, ~~2024~~2025, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Information regarding legal proceedings to which the Company is a party is set forth in Note 1413 – Legal Matters to our unaudited consolidated condensed financial statements and is incorporated herein by reference.

ITEM 1A. RISK FACTORS

In evaluating all forward-looking statements, you should specifically consider risk factors that may cause actual results to vary from those contained in the forward-looking statements. Various risk factors associated with our business are included in our Annual Report on Form 10-K for the year ended March 3029, ~~2024~~2025, as filed with the Commission on May 2423, ~~2024~~2025, and available at www.sec.gov. Other than as set forth below, there have been no material changes to those risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended March 3029, ~~2024~~2025.

We depend on a limited number of customers and distributors for a substantial portion of our sales, and the loss of, or a significant reduction in orders from, or pricing on products sold to, any key customer or distributor could significantly reduce our sales and our profitability.

While we generate sales from a broad base of customers worldwide, the loss of any of our key customers, or a significant reduction in sales or selling prices to any key customer, or reductions in selling prices made to retain key customer relationships, would significantly reduce our revenue, margins and earnings and adversely affect our business. For ~~each of~~ the ~~third quarters of fiscal years 2025 and 2024, our ten largest end customers represented approximately 96 percent of our net sales. For the~~ first nine months of fiscal years of 2025 and 2024, our ten largest end customers represented approximately 96 percent and 95 percent of our net sales, respectively. We had one end customer, Apple Inc., that purchased through multiple contract manufacturers and represented approximately 91 percent and 89 percent of the Company’s total net sales for the third quarter of fiscal years 2025 and 2024, respectively, and 90 percent and 87 percent for the first nine months of fiscal years of 2025 and 2024, respectively. No other end customer or distributor represented more than 10 percent of net sales for the three and nine months ended December 28, 2024, or December 30, 2023.

quarter of fiscal years 2026 and 2025, our ten largest end customers represented approximately 95 percent and 96 percent of our net sales, respectively. We had one end customer, Apple Inc., that purchased through multiple contract manufacturers and represented approximately 86 percent and 88 percent of the Company’s total net sales for the first quarter of fiscal years 2026 and 2025, respectively. No other end customer or distributor represented more than 10 percent of net sales for the three months ended June 28, 2025, or June 29, 2024.

We may not be able to maintain or increase sales to certain of our key customers for a variety of reasons, including:

- most of our customers can stop incorporating our products into their own products with limited notice to us and suffer little or no penalty;

- our agreements with our customers typically do not require them to purchase a minimum quantity of our products;

- many of our customers have pre-existing or concurrent relationships with our current or potential competitors that may affect the customers’ decisions to purchase our products;

- many of our customers have sufficient resources to internally develop technology solutions and semiconductor components that could replace the products that we currently supply in our customers’ end products;

- our customers face intense competition from other manufacturers that do not use our products;

- our customers may be subject to investigations and litigation that could result in injunctive or other relief that negatively impacts sales of their products, which in turn would result in a decrease in demand for our products;

- our customers regularly evaluate alternative sources of supply in order to diversify their supplier base, which increases their negotiating leverage with us and their ability to either obtain or dual-source components from other suppliers; and

- our current customers may be hesitant in some cases to award new business to us based on their desire to manage their supply chain risks around any potential over-dependence on a supplier or supply chain.

In addition, our dependence on a limited number of key customers may make it easier for them to demand favorable commercial terms or to pressure us on price reductions or to not accept price increases resulting from unexpected or additional cost increases or fees associated with our suppliers. We have experienced pricing pressure from certain key customers, and we expect that the average selling prices ("ASPs") for certain of our products will decline from time to time, potentially reducing our revenue, margins, and earnings.

Our key customer relationships often require us to develop new products that may involve significant technological challenges. Our customers frequently place considerable pressure on us to meet tight development schedules. In addition, we have entered, and may again enter in the future, into customer agreements providing for exclusivity periods during which we may only sell specified products or technology to a specific customer. Even without exclusivity periods, the products that we develop are often specific to our customer's system architecture and frequently cannot be sold to other customers. Accordingly, we have in the past and may in the future devote a substantial amount of resources to strategic relationships, which could detract from or delay our completion of other important development projects or the development of next-generation products and technologies. Notwithstanding our efforts, our customers are not always obligated to purchase new products that we develop for them, and their failure to do so could have a material effect on our operating results, financial condition, and cash flows.

Our reliance on certain customers may continue to increase, which could heighten the risks associated with having key customers, including making us more vulnerable to significant reductions in revenue, margins, and earnings; pricing pressure; and other adverse effects on our business.

negotiating leverage with us and their ability to either obtain or dual-source components from other suppliers; and- our current customers may be hesitant in some cases to award new business to us based on their desire to manage their supply chain risks around any potential over-dependence on a supplier or supply chain. In addition, our dependence on a limited number of key customers may make it easier for them to demand favorable commercial terms or to pressure us on price reductions or to not accept price increases resulting from unexpected or additional cost increases or fees associated with our suppliers. We have experienced pricing pressure from certain key customers, and we expect that the average selling prices ("ASPs") for certain of our products will decline from time to time, potentially reducing our revenue, margins, and earnings. Our key customer relationships often require us to develop new products that may involve significant technological challenges. Our customers frequently place considerable pressure on us to meet tight development schedules. In addition, we have entered, and may again enter in the future, into customer agreements providing for exclusivity periods during which we may only sell specified products or technology to a specific customer. Even without exclusivity periods, the products that we develop are often specific to our customer's system architecture and frequently cannot be sold to other customers. Accordingly, we have in the past and may in the future devote a substantial amount of resources to strategic relationships, which could detract from or delay our completion of other important development projects or the development of next-generation products and technologies. Notwithstanding our efforts, our customers are not always obligated to purchase new products that we develop for them, and their failure to do so could have a material effect on our operating results, financial condition, and cash flows. For example, in April 2023, we were informed that a new product that we had developed for a key customer for introduction in the fall of calendar 2023 was no longer expected to come to market as planned. Our reliance on certain customers may continue to increase, which could heighten the risks associated with having key customers, including making us more vulnerable to significant reductions in revenue, margins, and earnings; pricing pressure; and other adverse effects on our business.

We depend on the use of information technology systems; disruptions to these systems could impact our ability to perform necessary business operations and have an adverse impact on our financial condition.

Our business relies on the security and availability of our information technology systems and solutions, such as hardware, software, cloud services, and networks. This includes, among other things, human capital solutions, financial solutions, customer relationship management solutions, design and software development solutions and tools, and data center processing. While we own and manage some of these information technology systems directly, we also rely on third-party information technology systems in the operation of our business. Our operations could be harmed and our costs could increase if any of these systems are disrupted for any reason, including information technology system failures or cyber-attacks; natural disasters; power or water shortages; political, social or economic instability including military, terrorist, or other catastrophic events; labor disruptions; insolvency of third-parties on which we rely; or other operational issues or system failures. We have experienced outages in the past and could be subjected to periods in which our systems and solutions or the third-party systems on which we rely are negatively impacted, degraded or unavailable, potentially for extended periods of time. If this were to occur, we could be subject to data loss or corruption, inability to accurately process or record transactions, reputational harm, litigation, indemnity obligations and other liabilities, and our business, revenues, profitability and financial condition could be negatively impacted.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information about purchases of equity securities that are registered by us pursuant to Section 12 of the Exchange Act during the three months ended ~~December~~June 28, ~~2024~~2025 (in thousands, except per share amounts):

Monthly Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)
September 29, 2024 - October 26, 2024	—	$	—	—	$	224,147
March 30, 2025 - April 26, 2025	297	$	84.26	297	$	529,108
October 27, 2024 - November 23, 2024	610	$	102.58	610	$	161,604
April 27, 2025 - May 24, 2025	628	$	105.02	628	$	463,108
November 24, 2024 - December 28, 2024	69	$	108.53	69	$	154,110
May 25, 2025 - June 28, 2025	88	$	101.73	88	$	454,108
Total	~~679~~1,013	$	~~103~~98.1866	~~679~~1,013	$	~~154~~454,~~110~~108

(1) As of ~~December~~June 28, ~~2024~~2025, the Company has one active share repurchase authorization, the $500 million in share repurchases authorized by the Board of Directors in ~~July~~March ~~2022~~2025. Share repurchases are to be funded from existing cash and intended to be effected from time to time in accordance with applicable securities laws through the open market, including pursuant to a Rule 10b5-1 trading plan, or in privately negotiated transactions. The timing of repurchases and the actual amount purchased depend on a variety of factors including general market and economic conditions and other corporate considerations. The authorization does not have an expiration date, does not obligate the Company to repurchase any particular amount of common stock, and may be modified or suspended at any time at the Company's discretion. The Company repurchased 1.0 million shares of its common stock for $100.0 million during the first quarter of fiscal year 2026, completing the previous $500 million 2022 share repurchase authorization and beginning repurchases under the 2025 share repurchase authorization. The Company's repurchases reflected in the table above were made in the open market and were funded from existing cash. All shares of our common stock that were repurchased were retired as of ~~December~~June 28, ~~2024~~2025.

The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, which is included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity. Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Trading Arrangements

The following table details contracts, instructions and written plans for the purchase or sale of securities, which were entered into during the first quarter of fiscal year 2026. None of our directors or Section 16 officers entered into, ~~modified,~~ or terminated a ~~Rule 10b5-1 or~~ non-Rule 10b5-1 trading arrangement ~~for the purchase or sale of Company securities~~ during the ~~third~~first quarter of fiscal year ~~2025~~2026.

Name and Title

Action

Trading Arrangement (1)

Date of Adoption

Expiration Date

Aggregate Number of Securities to be Purchased or Sold Pursuant to the Trading Arrangement

Denise Grode

Adoption

Rule 10b5-1(c)

May 30, 2025

October 31, 2025

up to 4,410 to be sold

EVP, Chief Human Resources Officer

(1) Except as indicated by footnote, each trading arrangement marked as "Rule 10b5-1(c)" is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended.

ITEM 6. EXHIBITS

The following exhibits are filed as part of or incorporated by reference into this Report:

Number			Description
3.1			Amended and Restated Certificate of Incorporation of Registrant, filed with the Delaware Secretary of State on July 26, 2024 (1)
3.2			Amended and Restated Bylaws of Registrant (2)
10.1			Cirrus Logic, Inc. 2018 Long Term Incentive Plan Notice of Grant of MSU Performance Award
10.2			Cirrus Logic, Inc. 2018 Long Term Incentive Plan Notice of Grant of PSU Performance Award
31.1			Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2			Certification of ~~Principal~~Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*			Certification of Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*			Certification of ~~Principal~~Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS			Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH			Inline XBRL Taxonomy Extension Schema Document
101.CAL			Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB			Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE			Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF			Inline XBRL Taxonomy Extension Definition Linkbase Document
104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

1.Incorporated by reference to Exhibit 2 to the Registrant’s Definitive Proxy Statement filed with the Commission on June 3, 2024 (Registration No. 000-17795).

2.Incorporated by reference from Registrant’s Report on Form 8-K filed with the Commission on March 8, 2023 (Registration No. 000-17795).

* The certifications attached as Exhibits 32.1 and 32.2 accompanying this Quarterly Report on Form 10-Q are deemed furnished and not filed with the SEC and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CIRRUS LOGIC, INC.

Date:	~~February~~August 45, 2025	/s/ ~~Ulf~~Jeff ~~Habermann~~Woolard
		Ulf Habermann
		Jeff Woolard
		Interim Chief Financial Officer
		Chief Financial Officer

Filing Compare · CIRRUS LOGIC, INC.